Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Reports 5.7-Percent Increase in Q3 Revenue Amid Narrowed Losses

NEW YORK, Nov. 1 (GenomeWeb News) - Caliper today reported a 5.7-percent year-over-year revenue increase for the third quarter. The Hopkinton, Mass.-based biotech also narrowed its net loss by 25 percent.


For the quarter ended Sept. 30, Caliper reported revenues of $21.3 million, compared to $20.2 million in the third quarter of 2004. Of this, approximately $15.8 million was product revenue, while the rest resulted from service, contract, and license fees.


The company spent $4.2 million on R&D in the period, down from $5.2 million year over year.


Caliper's net losses for the quarter decreased to $3.9 million from $5.1 million in the same quarter last year.


As of Sept. 30, Caliper had cash, cash equivalents, and marketable securities of $34.8 million.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.